OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Editorial Board	192
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	146
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	95
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	91
Inhaled aerosol viral-vectored vaccines against tuberculosis	79
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	69
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	69
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	66
The enigmatic roles of Anelloviridae and Redondoviridae in humans	57
Transmission patterns of hepatitis E virus	54
Editorial Board	52
Structural basis for neutralization of enterovirus	49
Virus–host protein interactions as footprints of human cytomegalovirus replication	48
Editorial overview: Viral pathogenesis	47
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	44
Human placental models for studying viral infections	44
Editorial Board	43
Recent progress in development of monoclonal antibodies against human cytomegalovirus	41
New preventive strategies for respiratory syncytial virus infection in children	40
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	40
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	40
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1	38
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	37
The journey of herpesvirus capsids and genomes to the host cell nucleus	35
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	32

Emerging technologies in the study of the virome	32
Epigenetic control of the Epstein-Barr lifecycle	32
Platelets in the pathogenesis of flavivirus disease	30
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	29
Mitigation of evolved bacterial resistance to phage therapy	29
A complex immune communication between eicosanoids and pulmonary macrophages	28
Perspective on taxonomic classification of uncultivated viruses	28
Editorial Board	27
Asymmetry in icosahedral viruses	27
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	27
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	27
Engineering therapeutic phages for enhanced antibacterial efficacy	27
Retasking of canonical antiviral factors into proviral effectors	26
When good turns bad: how viruses exploit innate immunity factors	26
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	25
Tissue-resident memory T cells in protective immunity to influenza virus	24
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	24
Human organoid models to study coronavirus infections of the respiratory tract	24
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	24
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	23
Immune responses to human respiratory coronaviruses infection in mouse models	23
Modeling zoonotic and vector-borne viruses	23
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	23
Mechanisms of HCV resistance to broadly neutralizing antibodies	23
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	23
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	22
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	22
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	21
Deimmunization of flagellin adjuvant for clinical application	21
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	20
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	20
Oncogenic Animal Herpesviruses	20
Advances in human monoclonal antibody therapy for HBV infection	19
Antigenic evolution of SARS coronavirus 2	19
Editorial overview	18
Viral Z-RNA triggers ZBP1-dependent cell death	17
Broadly neutralizing antibodies against COVID-19	17
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	17
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	17
Editorial Board	16
Editorial Board	16
Early signaling pathways in virus-infected cells	15
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	15
Editorial overview: Viral immunology before COVID-19	15
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2	15
Editorial overview: Special issue on phage therapy	15
Editorial overview: Engineering elimination of chronic viral hepatitis	14
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	14
Accumulation of host cell genetic errors following high-risk HPV infection	14
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	14

How and why RNA genomes are (partially) ordered in viral capsids	14
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
Structural insights into hepatitis C virus neutralization	14
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers	14
Editorial overview: Special issue on virus structure and expression in current opinion in virology	13
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	13
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	13
The intestinal virome: lessons from animal models	13
Proteases and variants: context matters for SARS-CoV-2 entry assays	13
Editorial Board	13
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	13
Editorial overview: Virus structure and expression	13
Editorial Board	13
Editorial Board	12
Lying low-chromatin insulation in persistent DNA virus infection	12
Broad neutralizing antibody-based strategies to tackle influenza	12
Koala retrovirus and neoplasia: correlation and underlying mechanisms	12
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	12
Phage therapy for secondary bacterial infections with COVID-19	12
European regulatory aspects of phage therapy: magistral phage preparations	12
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	11
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	11
Zoonotic disease and virome diversity in bats	11
Animal models of SARS-CoV-2 transmission	11
Endocytosis of Bacteriophages	11
Therapeutic approaches to Epstein–Barr virus cancers	11
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	11
Virus structure and structure-based antivirals	11
The role of human lipoproteins for hepatitis C virus persistence	11
The long and winding road: human papillomavirus entry and subcellular trafficking	11
Editorial Board	11
Editorial Board	10
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology	10
Ex vivo culture models to study viral infections of the liver	10
An overview of the current state of phage therapy for the treatment of biofilm-related infections	10
Viral determinants influencing intra- and intercellular communication in cytomegalovirus infection	10
A comparative review of adenovirus A12 and C5 oncogenes	10
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	10
Know your enemy and know yourself – the case of SARS-CoV-2 host factors	10